|
|
| | trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone Basic information |
| | trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone Chemical Properties |
| Boiling point | 740.8±60.0 °C(Predicted) | | density | 1.30±0.1 g/cm3(Predicted) | | solubility | Chloroform, Dichloromethane | | form | Solid | | pka | 14.22±0.20(Predicted) | | color | Off-White | | CAS DataBase Reference | 87152-97-4 |
| | trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone Usage And Synthesis |
| Chemical Properties | Off-White Solid | | Uses | 2-Oxoquinoline derivative as blood platelet aggregation inhibitors. Intermediate of OPC-13013, a metabolite of Cilostazol. |
| | trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone Preparation Products And Raw materials |
|